First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody
A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, an...
Saved in:
Published in | Nature communications Vol. 13; no. 1; pp. 1219 - 15 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
09.03.2022
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
ISSN | 2041-1723 2041-1723 |
DOI | 10.1038/s41467-022-28727-5 |
Cover
Abstract | A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody,
89
Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in
89
Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia (
N
= 5) and on suppressive ART (
N
= 5) compared to uninfected controls (
N
= 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases.
Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly neutralizing antibody,
89
Zr-VRC01, and show that PET tracer lymph node uptake positively correlates with HIV protein levels measured directly from cells obtained from these tissues. This strategy may allow non-invasive characterization of residual HIV infection in the setting of therapeutic interventions. |
---|---|
AbstractList | A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody,
89
Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in
89
Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia (
N
= 5) and on suppressive ART (
N
= 5) compared to uninfected controls (
N
= 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases. Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly neutralizing antibody, 89Zr-VRC01, and show that PET tracer lymph node uptake positively correlates with HIV protein levels measured directly from cells obtained from these tissues. This strategy may allow non-invasive characterization of residual HIV infection in the setting of therapeutic interventions. A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89 Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89 Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia ( N = 5) and on suppressive ART ( N = 5) compared to uninfected controls ( N = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases. Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly neutralizing antibody, 89 Zr-VRC01, and show that PET tracer lymph node uptake positively correlates with HIV protein levels measured directly from cells obtained from these tissues. This strategy may allow non-invasive characterization of residual HIV infection in the setting of therapeutic interventions. A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia (N = 5) and on suppressive ART (N = 5) compared to uninfected controls (N = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases.Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly neutralizing antibody, 89Zr-VRC01, and show that PET tracer lymph node uptake positively correlates with HIV protein levels measured directly from cells obtained from these tissues. This strategy may allow non-invasive characterization of residual HIV infection in the setting of therapeutic interventions. A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia (N = 5) and on suppressive ART (N = 5) compared to uninfected controls (N = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases.A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia (N = 5) and on suppressive ART (N = 5) compared to uninfected controls (N = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases. |
ArticleNumber | 1219 |
Author | Munter, Sadie E. Schulte, Brailee Seo, Youngho Martinez-Ortiz, Enrique Reeves, Jacqueline D. Flavell, Robert R. Koup, Richard A. Wu, I-Wei Katherine Nixon, Christopher C. Henrich, Timothy J. Thanh, Cassandra Hyunh, Tony Petropoulos, Christos J. Deeks, Steven G. Chomont, Nicolas Franc, Benjamin L. Mascola, John R. Fehrman, Emily Deitchman, Amelia N. Torres, Leonel Aslam, Maya Pardons, Marion Kumar, Shreya Pan, Tony Gama, Lucio Beckford-Vera, Denis R. Ravanfar, Vahid VanBrocklin, Henry F. Hoh, Rebecca Iyer, Nikita S. |
Author_xml | – sequence: 1 givenname: Denis R. surname: Beckford-Vera fullname: Beckford-Vera, Denis R. organization: Department of Radiology and Biomedical Imaging, University of California San Francisco – sequence: 2 givenname: Robert R. orcidid: 0000-0002-8694-1199 surname: Flavell fullname: Flavell, Robert R. organization: Department of Radiology and Biomedical Imaging, University of California San Francisco – sequence: 3 givenname: Youngho orcidid: 0000-0001-5908-6636 surname: Seo fullname: Seo, Youngho organization: Department of Radiology and Biomedical Imaging, University of California San Francisco – sequence: 4 givenname: Enrique surname: Martinez-Ortiz fullname: Martinez-Ortiz, Enrique organization: Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco – sequence: 5 givenname: Maya surname: Aslam fullname: Aslam, Maya organization: Department of Radiology and Biomedical Imaging, University of California San Francisco – sequence: 6 givenname: Cassandra orcidid: 0000-0001-6458-3469 surname: Thanh fullname: Thanh, Cassandra organization: Division of Experimental Medicine, University of California San Francisco – sequence: 7 givenname: Emily surname: Fehrman fullname: Fehrman, Emily organization: Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco – sequence: 8 givenname: Marion surname: Pardons fullname: Pardons, Marion organization: Department of Microbiology, Infectiology and Immunology, Centre de Recherche du CHUM, Université de Montréal – sequence: 9 givenname: Shreya surname: Kumar fullname: Kumar, Shreya organization: Division of Experimental Medicine, University of California San Francisco – sequence: 10 givenname: Amelia N. orcidid: 0000-0002-4722-463X surname: Deitchman fullname: Deitchman, Amelia N. organization: Department of Clinical Pharmacy, University of California – sequence: 11 givenname: Vahid surname: Ravanfar fullname: Ravanfar, Vahid organization: Department of Radiology and Biomedical Imaging, University of California San Francisco – sequence: 12 givenname: Brailee surname: Schulte fullname: Schulte, Brailee organization: Department of Radiology and Biomedical Imaging, University of California San Francisco – sequence: 13 givenname: I-Wei Katherine surname: Wu fullname: Wu, I-Wei Katherine organization: Department of Radiology and Biomedical Imaging, University of California San Francisco – sequence: 14 givenname: Tony surname: Pan fullname: Pan, Tony organization: Division of Experimental Medicine, University of California San Francisco – sequence: 15 givenname: Jacqueline D. surname: Reeves fullname: Reeves, Jacqueline D. organization: Division of Experimental Medicine, University of California San Francisco – sequence: 16 givenname: Christopher C. surname: Nixon fullname: Nixon, Christopher C. organization: Division of Experimental Medicine, University of California San Francisco – sequence: 17 givenname: Nikita S. surname: Iyer fullname: Iyer, Nikita S. organization: Division of Experimental Medicine, University of California San Francisco – sequence: 18 givenname: Leonel surname: Torres fullname: Torres, Leonel organization: Division of Experimental Medicine, University of California San Francisco – sequence: 19 givenname: Sadie E. surname: Munter fullname: Munter, Sadie E. organization: Division of Experimental Medicine, University of California San Francisco – sequence: 20 givenname: Tony surname: Hyunh fullname: Hyunh, Tony organization: Department of Radiology and Biomedical Imaging, University of California San Francisco – sequence: 21 givenname: Christos J. orcidid: 0000-0001-5496-8090 surname: Petropoulos fullname: Petropoulos, Christos J. organization: Monogram Biosciences, Inc., Laboratory Corporation of America, South San Francisco – sequence: 22 givenname: Rebecca surname: Hoh fullname: Hoh, Rebecca organization: Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco – sequence: 23 givenname: Benjamin L. surname: Franc fullname: Franc, Benjamin L. organization: Department of Radiology, Stanford University – sequence: 24 givenname: Lucio surname: Gama fullname: Gama, Lucio organization: Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health – sequence: 25 givenname: Richard A. surname: Koup fullname: Koup, Richard A. organization: Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health – sequence: 26 givenname: John R. surname: Mascola fullname: Mascola, John R. organization: Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health – sequence: 27 givenname: Nicolas orcidid: 0000-0001-9747-5018 surname: Chomont fullname: Chomont, Nicolas organization: Department of Microbiology, Infectiology and Immunology, Centre de Recherche du CHUM, Université de Montréal – sequence: 28 givenname: Steven G. orcidid: 0000-0001-6371-747X surname: Deeks fullname: Deeks, Steven G. organization: Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco – sequence: 29 givenname: Henry F. orcidid: 0000-0003-2849-0841 surname: VanBrocklin fullname: VanBrocklin, Henry F. email: Henry.Vanbrocklin@ucsf.edu organization: Department of Radiology and Biomedical Imaging, University of California San Francisco – sequence: 30 givenname: Timothy J. orcidid: 0000-0002-6684-0622 surname: Henrich fullname: Henrich, Timothy J. email: Timothy.Henrich@ucsf.edu organization: Division of Experimental Medicine, University of California San Francisco |
BookMark | eNp9Uk1v1TAQtFARLaV_gFMkLlxM_Rk7FyT01NInVQKh0gMXy3ac1E-JXeyk0uPX4zRFtD3UF6-8M7O7nn0LDkIMDoD3GH3CiMrTzDCrBUSEQCIFEZC_AkcEMQyxIPTgUXwITnLeoXJogyVjb8Ah5aRmnDdHYHfuU56gD_BmHnWo_DjOIX4_uyqR7n3oq9hVF9triCsfOmcnH0M15yUhm18JDtq4wbXV9Y8NwpVJUbfDvgpunpIe_J8Fp8PkTWz378DrTg_ZnTzcx-Dn-dnV5gJefvu63Xy5hJZjOsGOIoYEJ4TWzDDRyMYIwzTqSmwZcwijjrYNwowS40hLKDfCtcY0THJnCT0G21W3jXqnblMZJO1V1F7dP8TUK50mbwenGNEYOyRr1HbMYFLqYc0Y7bTshLOmaH1etW5nM7rWurDM9UT0aSb4G9XHOyUbJCjnReDjg0CKv2eXJzX6bN0w6ODinBWpqSweFmsK9MMz6C7OKZSvWlCiZlJgUVByRdkUc06uU9ZPerGl1PeDwkgt-6HW_VBFW93vh1p6Ic-o_-Z4kURXUi7g0Lv0v6sXWH8B3TjMQQ |
CitedBy_id | crossref_primary_10_3390_v15051126 crossref_primary_10_1093_pnasnexus_pgad446 crossref_primary_10_1093_infdis_jiad247 crossref_primary_10_1007_s00259_025_07110_8 crossref_primary_10_1093_infdis_jiad223 crossref_primary_10_3389_fnume_2024_1360710 crossref_primary_10_1038_s41590_024_01948_0 crossref_primary_10_1016_j_ijpharm_2024_123795 crossref_primary_10_3390_biomedicines11020617 crossref_primary_10_1016_j_trac_2023_117470 crossref_primary_10_1128_cmr_00152_22 crossref_primary_10_1007_s12149_024_01979_5 crossref_primary_10_1038_s41467_024_54580_9 crossref_primary_10_1038_s44303_024_00056_w crossref_primary_10_1016_j_isci_2025_111795 crossref_primary_10_1080_14787210_2023_2184345 crossref_primary_10_7554_eLife_89837 crossref_primary_10_1089_aid_2022_0180 crossref_primary_10_1186_s40658_024_00666_8 crossref_primary_10_7554_eLife_89837_3 crossref_primary_10_1093_infdis_jiad079 crossref_primary_10_3389_fmed_2022_979756 crossref_primary_10_1053_j_semnuclmed_2023_03_001 crossref_primary_10_1371_journal_ppat_1012888 crossref_primary_10_1021_acsinfecdis_2c00573 crossref_primary_10_3390_ijms24054374 crossref_primary_10_1097_COH_0000000000000840 crossref_primary_10_3389_fmed_2023_1178528 |
Cites_doi | 10.2967/jnumed.112.108530 10.1097/00126334-200101010-00001 10.1002/psp4.12224 10.1038/nm.4411 10.2967/jnumed.115.155309 10.1097/RLU.0000000000002229 10.1053/j.sult.2010.10.001 10.1128/JVI.00754-11 10.1073/pnas.1414148111 10.1056/NEJMoa1608243 10.1007/s11307-019-01363-0 10.1038/387183a0 10.2967/jnumed.117.190736 10.1128/JVI.76.7.3522-3533.2002 10.1128/JVI.00734-12 10.1371/journal.pone.0193832 10.1126/science.278.5341.1295 10.1038/mi.2008.23 10.1186/s13550-016-0208-5 10.1093/infdis/jiv504 10.1016/j.str.2015.07.020 10.1002/jlcr.3605 10.1097/QAD.0b013e3280117204 10.1038/nm880 10.1021/acs.chemrev.9b00738 10.1073/pnas.122696599 10.1038/nmeth.3320 10.1086/656722 10.1073/pnas.1414926112 10.2967/jnumed.118.224568 10.1038/nprot.2010.13 10.1126/science.1192819 10.1086/654816 10.1007/s40495-018-0142-5 10.1007/s00259-019-04307-6 10.1007/s00259-009-1263-1 10.1126/science.1187659 10.1016/j.ebiom.2021.103252 10.1371/journal.pmed.1002435 10.1038/mi.2017.112 10.1371/journal.ppat.1007619 10.3389/fimmu.2019.02077 10.1126/scitranslmed.aad5752 10.1097/01.qai.0000230524.71717.14 10.1172/JCI134815 10.3791/52521 10.7326/M14-1027 10.1128/JVI.01344-18 10.7554/eLife.46916 10.2967/jnumed.117.207670 |
ContentType | Journal Article |
Copyright | The Author(s) 2022 The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022. The Author(s). |
Copyright_xml | – notice: The Author(s) 2022 – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022. The Author(s). |
DBID | C6C AAYXX CITATION 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA |
DOI | 10.1038/s41467-022-28727-5 |
DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest : Biological Science Collection journals [unlimited simultaneous users] ProQuest Central Technology Collection ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Proquest Medical Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 15 |
ExternalDocumentID | oai_doaj_org_article_42a11e0860df4b12b471a443fa8f7ecb PMC8907355 10_1038_s41467_022_28727_5 |
GrantInformation_xml | – fundername: U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) – fundername: U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) grantid: UM1AI126611; R01AI152932 funderid: https://doi.org/10.13039/100000060 – fundername: amfAR, The Foundation for AIDS Research (amfAR) grantid: Institute for Cure Research funderid: https://doi.org/10.13039/100001117 – fundername: ; – fundername: ; grantid: Institute for Cure Research – fundername: ; grantid: UM1AI126611; R01AI152932 |
GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AARCD AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 SOI 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c513t-f30407522364b47989b7b4a0f479c44e010f3d901432be2d235b7edbb9485ec23 |
IEDL.DBID | M48 |
ISSN | 2041-1723 |
IngestDate | Wed Aug 27 01:32:17 EDT 2025 Thu Aug 21 18:33:56 EDT 2025 Fri Sep 05 02:43:05 EDT 2025 Wed Aug 13 11:25:08 EDT 2025 Thu Apr 24 22:53:03 EDT 2025 Tue Jul 01 04:17:46 EDT 2025 Fri Feb 21 02:38:52 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c513t-f30407522364b47989b7b4a0f479c44e010f3d901432be2d235b7edbb9485ec23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6684-0622 0000-0001-9747-5018 0000-0001-5908-6636 0000-0001-5496-8090 0000-0002-4722-463X 0000-0001-6371-747X 0000-0002-8694-1199 0000-0001-6458-3469 0000-0003-2849-0841 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41467-022-28727-5 |
PMID | 35264559 |
PQID | 2637648717 |
PQPubID | 546298 |
PageCount | 15 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_42a11e0860df4b12b471a443fa8f7ecb pubmedcentral_primary_oai_pubmedcentral_nih_gov_8907355 proquest_miscellaneous_2638022039 proquest_journals_2637648717 crossref_citationtrail_10_1038_s41467_022_28727_5 crossref_primary_10_1038_s41467_022_28727_5 springer_journals_10_1038_s41467_022_28727_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-09 |
PublicationDateYYYYMMDD | 2022-03-09 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-09 day: 09 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationYear | 2022 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Siliciano (CR3) 2003; 9 Gilbert (CR18) 2010; 202 Chun (CR14) 2014; 111 Yukl (CR31) 2010; 202 McMahon (CR35) 2021; 65 Ryman, Meibohm (CR43) 2017; 6 Wu (CR49) 2010; 329 McKnight, Viola-Villegas (CR39) 2018; 61 CR33 CR32 Rothenberger (CR36) 2015; 112 Nilsson (CR27) 2007; 21 Ouyang (CR22) 2018; 43 Perk (CR46) 2010; 37 Boktor, Walker, Stacey, Gledhill, Pitman (CR26) 2013; 54 Vosjan (CR45) 2010; 5 Bar (CR9) 2016; 375 Mayer (CR10) 2017; 14 Finzi (CR2) 1997; 278 Kinahan, Fletcher (CR19) 2010; 31 Diao, Meibohm (CR44) 2018; 4 Lynch (CR11) 2015; 7 Wei (CR37) 2020; 120 CR5 Butof (CR21) 2015; 56 Henrich, Hsue, VanBrocklin (CR8) 2019; 10 Jauw (CR38) 2019; 60 Lineberger, Danzeisen, Hazuda, Simon, Miller (CR41) 2002; 76 Sheth (CR29) 2008; 1 Estes (CR4) 2017; 23 Hofheinz (CR25) 2019; 46 Santangelo (CR6) 2015; 12 Lynch (CR17) 2012; 86 Beckford Vera (CR47) 2018; 13 Beckford-Vera (CR48) 2020; 22 CR16 CR15 Zhou (CR12) 2010; 329 Talal (CR30) 2001; 26 CR50 Li (CR13) 2011; 85 Hofheinz, Apostolova, Oehme, Kotzerke, van den Hoff (CR23) 2017; 58 Poles (CR28) 2006; 43 Pardons (CR34) 2019; 15 Hofheinz (CR20) 2016; 6 Santangelo (CR7) 2018; 11 Chun (CR1) 1997; 387 Lee, de Val, Lyumkis, Ward (CR42) 2015; 23 CR24 Henrich (CR51) 2016; 213 Miranda, Schaefer, Kupfer, Hu, Franzusoff (CR40) 2002; 99 JD Siliciano (28727_CR3) 2003; 9 RR Boktor (28727_CR26) 2013; 54 MK Rothenberger (28727_CR36) 2015; 112 28727_CR5 JH McMahon (28727_CR35) 2021; 65 28727_CR24 YWS Jauw (28727_CR38) 2019; 60 X Wu (28727_CR49) 2010; 329 J Nilsson (28727_CR27) 2007; 21 RM Lynch (28727_CR11) 2015; 7 TW Chun (28727_CR1) 1997; 387 KJ Bar (28727_CR9) 2016; 375 TJ Henrich (28727_CR51) 2016; 213 SA Yukl (28727_CR31) 2010; 202 JT Ryman (28727_CR43) 2017; 6 P Gilbert (28727_CR18) 2010; 202 PJ Santangelo (28727_CR7) 2018; 11 DR Beckford Vera (28727_CR47) 2018; 13 F Hofheinz (28727_CR25) 2019; 46 JD Estes (28727_CR4) 2017; 23 28727_CR33 28727_CR32 ML Ouyang (28727_CR22) 2018; 43 PE Kinahan (28727_CR19) 2010; 31 MA Poles (28727_CR28) 2006; 43 L Diao (28727_CR44) 2018; 4 M Pardons (28727_CR34) 2019; 15 TW Chun (28727_CR14) 2014; 111 DR Beckford-Vera (28727_CR48) 2020; 22 RM Lynch (28727_CR17) 2012; 86 W Wei (28727_CR37) 2020; 120 LR Perk (28727_CR46) 2010; 37 KH Mayer (28727_CR10) 2017; 14 MJ Vosjan (28727_CR45) 2010; 5 AH Talal (28727_CR30) 2001; 26 R Butof (28727_CR21) 2015; 56 T Zhou (28727_CR12) 2010; 329 LR Miranda (28727_CR40) 2002; 99 Y Li (28727_CR13) 2011; 85 TJ Henrich (28727_CR8) 2019; 10 28727_CR16 28727_CR15 F Hofheinz (28727_CR23) 2017; 58 BN McKnight (28727_CR39) 2018; 61 JE Lineberger (28727_CR41) 2002; 76 JH Lee (28727_CR42) 2015; 23 PJ Santangelo (28727_CR6) 2015; 12 28727_CR50 D Finzi (28727_CR2) 1997; 278 PM Sheth (28727_CR29) 2008; 1 F Hofheinz (28727_CR20) 2016; 6 |
References_xml | – volume: 54 start-page: 677 year: 2013 end-page: 682 ident: CR26 article-title: Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET publication-title: J. Nucl. Med. doi: 10.2967/jnumed.112.108530 – volume: 26 start-page: 1 year: 2001 end-page: 7 ident: CR30 article-title: Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue publication-title: J. Acquir. Immune Defic. Syndr. doi: 10.1097/00126334-200101010-00001 – ident: CR16 – volume: 6 start-page: 576 year: 2017 end-page: 588 ident: CR43 article-title: Pharmacokinetics of monoclonal antibodies publication-title: CPT Pharmacomet. Syst. Pharm. doi: 10.1002/psp4.12224 – volume: 23 start-page: 1271 year: 2017 end-page: 1276 ident: CR4 article-title: Defining total-body AIDS-virus burden with implications for curative strategies publication-title: Nat. Med. doi: 10.1038/nm.4411 – volume: 56 start-page: 1150 year: 2015 end-page: 1156 ident: CR21 article-title: Prognostic value of pretherapeutic tumor-to-blood standardized uptake ratio in patients with esophageal carcinoma publication-title: J. Nucl. Med. doi: 10.2967/jnumed.115.155309 – volume: 43 start-page: 715 year: 2018 end-page: 720 ident: CR22 article-title: Prediction of occult lymph node metastasis using tumor-to-blood standardized uptake ratio and metabolic parameters in clinical N0 lung adenocarcinoma publication-title: Clin. Nucl. Med. doi: 10.1097/RLU.0000000000002229 – volume: 31 start-page: 496 year: 2010 end-page: 505 ident: CR19 article-title: Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy publication-title: Semin. Ultrasound CT MR doi: 10.1053/j.sult.2010.10.001 – volume: 85 start-page: 8954 year: 2011 end-page: 8967 ident: CR13 article-title: Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01 publication-title: J. Virol. doi: 10.1128/JVI.00754-11 – volume: 111 start-page: 13151 year: 2014 end-page: 13156 ident: CR14 article-title: Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1414148111 – volume: 375 start-page: 2037 year: 2016 end-page: 2050 ident: CR9 article-title: Effect of HIV antibody VRC01 on viral rebound after treatment interruption publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1608243 – volume: 22 start-page: 105 year: 2020 end-page: 114 ident: CR48 article-title: PET/CT imaging of human TNFalpha using [(89)Zr]certolizumab pegol in a transgenic preclinical model of rheumatoid arthritis publication-title: Mol. Imaging Biol. doi: 10.1007/s11307-019-01363-0 – volume: 387 start-page: 183 year: 1997 end-page: 188 ident: CR1 article-title: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection publication-title: Nature doi: 10.1038/387183a0 – volume: 58 start-page: 1770 year: 2017 end-page: 1775 ident: CR23 article-title: Test-retest variability in lesion SUV and lesion SUR in (18)F-FDG PET: an analysis of data from two prospective multicenter trials publication-title: J. Nucl. Med. doi: 10.2967/jnumed.117.190736 – volume: 76 start-page: 3522 year: 2002 end-page: 3533 ident: CR41 article-title: Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion publication-title: J. Virol. doi: 10.1128/JVI.76.7.3522-3533.2002 – ident: CR15 – volume: 86 start-page: 7588 year: 2012 end-page: 7595 ident: CR17 article-title: The development of CD4 binding site antibodies during HIV-1 infection publication-title: J. Virol. doi: 10.1128/JVI.00734-12 – volume: 13 start-page: e0193832 year: 2018 ident: CR47 article-title: Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors publication-title: PLoS ONE doi: 10.1371/journal.pone.0193832 – ident: CR50 – volume: 278 start-page: 1295 year: 1997 end-page: 1300 ident: CR2 article-title: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy publication-title: Science doi: 10.1126/science.278.5341.1295 – ident: CR32 – volume: 1 start-page: 382 year: 2008 end-page: 388 ident: CR29 article-title: Immune reconstitution in the sigmoid colon after long-term HIV therapy publication-title: Mucosal Immunol. doi: 10.1038/mi.2008.23 – volume: 6 year: 2016 ident: CR20 article-title: Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET publication-title: EJNMMI Res. doi: 10.1186/s13550-016-0208-5 – volume: 213 start-page: 766 year: 2016 end-page: 770 ident: CR51 article-title: CCR5-Delta32 heterozygosity, HIV-1 reservoir size, and lymphocyte activation in individuals receiving long-term suppressive antiretroviral therapy publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiv504 – ident: CR5 – volume: 23 start-page: 1943 year: 2015 end-page: 1951 ident: CR42 article-title: Model building and refinement of a natively glycosylated HIV-1 Env protein by high-resolution cryoelectron microscopy publication-title: Structure doi: 10.1016/j.str.2015.07.020 – volume: 61 start-page: 727 year: 2018 end-page: 738 ident: CR39 article-title: (89) Zr-ImmunoPET companion diagnostics and their impact in clinical drug development publication-title: J. Label. Comp. Radiopharm. doi: 10.1002/jlcr.3605 – volume: 21 start-page: 565 year: 2007 end-page: 574 ident: CR27 article-title: Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection publication-title: Aids doi: 10.1097/QAD.0b013e3280117204 – volume: 9 start-page: 727 year: 2003 end-page: 728 ident: CR3 article-title: Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4(+) T cells publication-title: Nat. Med. doi: 10.1038/nm880 – ident: CR33 – volume: 120 start-page: 3787 year: 2020 end-page: 3851 ident: CR37 article-title: ImmunoPET: concept, design, and applications publication-title: Chem. Rev. doi: 10.1021/acs.chemrev.9b00738 – volume: 99 start-page: 8031 year: 2002 end-page: 8036 ident: CR40 article-title: Cell surface expression of the HIV-1 envelope glycoproteins is directed from intracellular CTLA-4-containing regulated secretory granules publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.122696599 – volume: 12 start-page: 427 year: 2015 end-page: 432 ident: CR6 article-title: Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques publication-title: Nat. Methods doi: 10.1038/nmeth.3320 – volume: 202 start-page: 1553 year: 2010 end-page: 1561 ident: CR31 article-title: Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy publication-title: J. Infect. Dis. doi: 10.1086/656722 – volume: 112 start-page: E1126 year: 2015 end-page: E1134 ident: CR36 article-title: Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1414926112 – volume: 60 start-page: 1825 year: 2019 end-page: 1832 ident: CR38 article-title: (89)Zr-Immuno-PET: toward a noninvasive clinical tool to measure target engagement of therapeutic antibodies in vivo publication-title: J. Nucl. Med. doi: 10.2967/jnumed.118.224568 – volume: 5 start-page: 739 year: 2010 end-page: 743 ident: CR45 article-title: Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine publication-title: Nat. Protoc. doi: 10.1038/nprot.2010.13 – volume: 329 start-page: 811 year: 2010 end-page: 817 ident: CR12 article-title: Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 publication-title: Science doi: 10.1126/science.1192819 – volume: 202 start-page: 595 year: 2010 end-page: 605 ident: CR18 article-title: Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine publication-title: J. Infect. Dis. doi: 10.1086/654816 – volume: 4 start-page: 285 year: 2018 end-page: 291 ident: CR44 article-title: Pharmacometric applications and challenges in the development of therapeutic antibodies in immuno-oncology publication-title: Curr. Pharm. Rep. doi: 10.1007/s40495-018-0142-5 – volume: 46 start-page: 1485 year: 2019 end-page: 1494 ident: CR25 article-title: Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma publication-title: Eur. J. Nucl. Med Mol. Imaging doi: 10.1007/s00259-019-04307-6 – volume: 37 start-page: 250 year: 2010 end-page: 259 ident: CR46 article-title: p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging publication-title: Eur. J. Nucl. Med. Mol. Imaging doi: 10.1007/s00259-009-1263-1 – volume: 329 start-page: 856 year: 2010 end-page: 861 ident: CR49 article-title: Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 publication-title: Science doi: 10.1126/science.1187659 – volume: 65 start-page: 103252 year: 2021 ident: CR35 article-title: A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103252 – volume: 14 start-page: e1002435 year: 2017 ident: CR10 article-title: Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: results of a phase 1 randomized trial publication-title: PLoS Med. doi: 10.1371/journal.pmed.1002435 – volume: 11 start-page: 932 year: 2018 end-page: 946 ident: CR7 article-title: Early treatment of SIV+ macaques with an alpha4beta7 mAb alters virus distribution and preserves CD4(+) T cells in later stages of infection publication-title: Mucosal Immunol. doi: 10.1038/mi.2017.112 – volume: 15 start-page: e1007619 year: 2019 ident: CR34 article-title: Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1007619 – volume: 10 start-page: 2077 year: 2019 ident: CR8 article-title: Seeing is believing: nuclear imaging of HIV persistence publication-title: Front Immunol. doi: 10.3389/fimmu.2019.02077 – volume: 7 start-page: 319ra206 year: 2015 ident: CR11 article-title: Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aad5752 – ident: CR24 – volume: 43 start-page: 65 year: 2006 end-page: 68 ident: CR28 article-title: Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals publication-title: J. Acquir. Immune Defic. Syndr. doi: 10.1097/01.qai.0000230524.71717.14 – volume: 278 start-page: 1295 year: 1997 ident: 28727_CR2 publication-title: Science doi: 10.1126/science.278.5341.1295 – volume: 202 start-page: 595 year: 2010 ident: 28727_CR18 publication-title: J. Infect. Dis. doi: 10.1086/654816 – volume: 22 start-page: 105 year: 2020 ident: 28727_CR48 publication-title: Mol. Imaging Biol. doi: 10.1007/s11307-019-01363-0 – volume: 10 start-page: 2077 year: 2019 ident: 28727_CR8 publication-title: Front Immunol. doi: 10.3389/fimmu.2019.02077 – volume: 202 start-page: 1553 year: 2010 ident: 28727_CR31 publication-title: J. Infect. Dis. doi: 10.1086/656722 – volume: 120 start-page: 3787 year: 2020 ident: 28727_CR37 publication-title: Chem. Rev. doi: 10.1021/acs.chemrev.9b00738 – volume: 4 start-page: 285 year: 2018 ident: 28727_CR44 publication-title: Curr. Pharm. Rep. doi: 10.1007/s40495-018-0142-5 – volume: 21 start-page: 565 year: 2007 ident: 28727_CR27 publication-title: Aids doi: 10.1097/QAD.0b013e3280117204 – volume: 23 start-page: 1271 year: 2017 ident: 28727_CR4 publication-title: Nat. Med. doi: 10.1038/nm.4411 – volume: 56 start-page: 1150 year: 2015 ident: 28727_CR21 publication-title: J. Nucl. Med. doi: 10.2967/jnumed.115.155309 – volume: 7 start-page: 319ra206 year: 2015 ident: 28727_CR11 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aad5752 – volume: 15 start-page: e1007619 year: 2019 ident: 28727_CR34 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1007619 – volume: 111 start-page: 13151 year: 2014 ident: 28727_CR14 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1414148111 – volume: 58 start-page: 1770 year: 2017 ident: 28727_CR23 publication-title: J. Nucl. Med. doi: 10.2967/jnumed.117.190736 – volume: 112 start-page: E1126 year: 2015 ident: 28727_CR36 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1414926112 – volume: 61 start-page: 727 year: 2018 ident: 28727_CR39 publication-title: J. Label. Comp. Radiopharm. doi: 10.1002/jlcr.3605 – volume: 43 start-page: 65 year: 2006 ident: 28727_CR28 publication-title: J. Acquir. Immune Defic. Syndr. doi: 10.1097/01.qai.0000230524.71717.14 – volume: 60 start-page: 1825 year: 2019 ident: 28727_CR38 publication-title: J. Nucl. Med. doi: 10.2967/jnumed.118.224568 – volume: 86 start-page: 7588 year: 2012 ident: 28727_CR17 publication-title: J. Virol. doi: 10.1128/JVI.00734-12 – volume: 13 start-page: e0193832 year: 2018 ident: 28727_CR47 publication-title: PLoS ONE doi: 10.1371/journal.pone.0193832 – volume: 26 start-page: 1 year: 2001 ident: 28727_CR30 publication-title: J. Acquir. Immune Defic. Syndr. doi: 10.1097/00126334-200101010-00001 – volume: 375 start-page: 2037 year: 2016 ident: 28727_CR9 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1608243 – volume: 54 start-page: 677 year: 2013 ident: 28727_CR26 publication-title: J. Nucl. Med. doi: 10.2967/jnumed.112.108530 – ident: 28727_CR5 doi: 10.1172/JCI134815 – volume: 99 start-page: 8031 year: 2002 ident: 28727_CR40 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.122696599 – ident: 28727_CR16 doi: 10.3791/52521 – ident: 28727_CR50 doi: 10.7326/M14-1027 – volume: 329 start-page: 856 year: 2010 ident: 28727_CR49 publication-title: Science doi: 10.1126/science.1187659 – ident: 28727_CR15 – volume: 37 start-page: 250 year: 2010 ident: 28727_CR46 publication-title: Eur. J. Nucl. Med. Mol. Imaging doi: 10.1007/s00259-009-1263-1 – volume: 213 start-page: 766 year: 2016 ident: 28727_CR51 publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiv504 – volume: 76 start-page: 3522 year: 2002 ident: 28727_CR41 publication-title: J. Virol. doi: 10.1128/JVI.76.7.3522-3533.2002 – volume: 5 start-page: 739 year: 2010 ident: 28727_CR45 publication-title: Nat. Protoc. doi: 10.1038/nprot.2010.13 – ident: 28727_CR33 doi: 10.1128/JVI.01344-18 – ident: 28727_CR32 doi: 10.7554/eLife.46916 – volume: 1 start-page: 382 year: 2008 ident: 28727_CR29 publication-title: Mucosal Immunol. doi: 10.1038/mi.2008.23 – volume: 9 start-page: 727 year: 2003 ident: 28727_CR3 publication-title: Nat. Med. doi: 10.1038/nm880 – volume: 6 year: 2016 ident: 28727_CR20 publication-title: EJNMMI Res. doi: 10.1186/s13550-016-0208-5 – volume: 31 start-page: 496 year: 2010 ident: 28727_CR19 publication-title: Semin. Ultrasound CT MR doi: 10.1053/j.sult.2010.10.001 – volume: 329 start-page: 811 year: 2010 ident: 28727_CR12 publication-title: Science doi: 10.1126/science.1192819 – volume: 85 start-page: 8954 year: 2011 ident: 28727_CR13 publication-title: J. Virol. doi: 10.1128/JVI.00754-11 – volume: 6 start-page: 576 year: 2017 ident: 28727_CR43 publication-title: CPT Pharmacomet. Syst. Pharm. doi: 10.1002/psp4.12224 – volume: 14 start-page: e1002435 year: 2017 ident: 28727_CR10 publication-title: PLoS Med. doi: 10.1371/journal.pmed.1002435 – volume: 23 start-page: 1943 year: 2015 ident: 28727_CR42 publication-title: Structure doi: 10.1016/j.str.2015.07.020 – ident: 28727_CR24 doi: 10.2967/jnumed.117.207670 – volume: 11 start-page: 932 year: 2018 ident: 28727_CR7 publication-title: Mucosal Immunol. doi: 10.1038/mi.2017.112 – volume: 43 start-page: 715 year: 2018 ident: 28727_CR22 publication-title: Clin. Nucl. Med. doi: 10.1097/RLU.0000000000002229 – volume: 46 start-page: 1485 year: 2019 ident: 28727_CR25 publication-title: Eur. J. Nucl. Med Mol. Imaging doi: 10.1007/s00259-019-04307-6 – volume: 12 start-page: 427 year: 2015 ident: 28727_CR6 publication-title: Nat. Methods doi: 10.1038/nmeth.3320 – volume: 387 start-page: 183 year: 1997 ident: 28727_CR1 publication-title: Nature doi: 10.1038/387183a0 – volume: 65 start-page: 103252 year: 2021 ident: 28727_CR35 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103252 |
SSID | ssj0000391844 |
Score | 2.5102544 |
Snippet | A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells... Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly... |
SourceID | doaj pubmedcentral proquest crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 1219 |
SubjectTerms | 13/1 13/31 45/22 45/23 45/90 45/91 59/57 59/78 631/250/255/1901 692/308/575 692/699/255/1901 Antibodies Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Biopsy CD4 antigen HIV Human immunodeficiency virus Humanities and Social Sciences Infections Infectious diseases Lymph nodes Lymphatic system Lymphocytes Lymphocytes T Medical imaging multidisciplinary Neutralizing Positron emission Positron emission tomography Protein expression Proteins Remission Science Science (multidisciplinary) Therapeutic applications Tissues Tomography Transcription Viremia Zirconium isotopes |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1daxQxMEhB8EX8xNUqEXzT0N0km4_HWnqcgiLSluJL2NkkeqXsyvXu4fz1nWT3zm5BffEtbGbZJPO9M5kh5A0oD6aNLdMVCCat8gxqKZhqhYqoc2LI4YJPn9X8VH48r89vtPpKOWFDeeDh4A4kb6oqoOFd-iih4oDStJFSxMZEHVpI0re05Q1nKstgYdF1keMtmVKYgyuZZUJKXkcngWtWTzRRLtg_sTJv50jeCpRm_TN7QO6PhiM9HBb8kNwJ3SNyd2gluXlMLmYLtOPYomO56x5dpHsf_ZfjExzlRkS0j3T-4YxVdJt_1dGU9P6dGvttyZAYUAF5evb1qKwoLPvGX25oF9b5T8ivBIc4WEDvN0_I6ez45GjOxj4KrK0rsWJRIKdqNLSEknh81ljQIJsy4riVMqBLFoVP8VTBIXDPRQ06eIBUOSa0XDwle13fhWeENlJxr8pW62BlHYRpSjAaFAiI3HJTkGp7pq4di4ynXheXLge7hXEDHhziwWU8uLogb3fv_BxKbPwV-n1C1Q4ylcfOD5Bo3Eg07l9EU5D9LaLdyLNXjisUtui_Vbogr3fTyG0phNJ0oV9nmHw3WdiC6AmBTBY0nekWP3LdbmNRnta4g3dbUvr98T9v-Pn_2PALco8n0k_Jc3af7K2W6_ASrakVvMqMcw0_eRmv priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1La9swWHQpg13GnsxrNzTYbRO1JVmSD2OsJSEbLJTSlrKLsF5dRrHbNDlkv36fFDvFhfUmrM9Y8veUvhdCH41wRtlgiSwMI7wSjpiSMyIsEwF0TvDJXfBzJqZn_MdFebGDZn0uTAyr7GViEtSutfGO_IAKYAWwrgv59fqGxK5R0bvat9Cou9YK7ksqMfYI7YJILvMR2j0cz45PtrcusR664rzLnsmZOrjlSVbEoHY4PFBJyoGGSoX8B9bn_djJew7UpJcmz9DTzqDE3zYU8Bzt-OYFerxpMbl-if5M5mDfkXlDUjc-PI_5IO3x-BRGqUERbgOefj8nBe7jshocg-Evsap-LQgQCSgmh89PjvICm0Vbu6s1bvwq3ZD8jXCAm7lp3foVOpuMT4-mpOuvQGxZsCUJDDhYggHGBDdcVqoy0vA6DzC2nHs4qgXmop-VUeOpo6w00jtjYkUZbyl7jUZN2_g3CNdcUCdyK6WveOmZqnOjpBGGmUArqjJU9P9U2674eOyBcaWTE5wpvcGDBjzohAddZujT9p3rTemNB6EPI6q2kLFsdnrQLi51x4Wa07ooPJziche4KSjsuqg5Z6FWQXprMrTfI1p3vHyr7ygvQx-208CF0bVSN75dJZiUs8yqDMkBgQwWNJxp5r9TPW9VgZwtYQefe1K6-_j_N_z24bXuoSc0EnUMl6v20Wi5WPl3YD8tzfuOKf4BkW0XfA priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1di9QwMJwngi_iJ1ZPieCbBpuPJumjLresgiJydxy-hE6TnCtHK3u7D-uvd5JtV3qo4FtoJjTJzGQmmS9CXoL2YNvYMsNBMlVrz6BSkulW6ogyJ4ZsLvj4SS9O1Yfz6vyAiDEWJjvt55SW-ZgevcPeXKnM0sn3HHV8YVh1g9y0RlaJqmd6tn9XSRnPrVJDfEwp7R-GTmRQTtU_0S-ve0deM5FmyTO_S-4MKiN9u5vkPXIQuvvk1q6I5PYB-T5fogbHlh3L9fboMkV89J-PT7CVSxDRPtLF-zPG6eh51dHk7n5Bbf11xZAMUPR4evZlVnIKq77xl1vahU1-A_mZ4HD3l9D77UNyOj8-mS3YUEGBtRWXaxYl8qhBFUtqBcrUtgYDqikjtlulAl7GovTJkioFBOGFrMAED5ByxoRWyEfksOu78JjQRmnhddkaE2pVBWmbEqwBDRKiqIUtCB_31LVDevFU5eLSZTO3tG6HB4d4cBkPrirIq_2YH7vkGv-EfpdQtYdMibHzh3514QZCcUo0nAe8p5U-KuACV80bpWRsbDShhYIcjYh2A7deOaHxmMWbGzcFebHvRj5LxpOmC_0mw-SoZFkXxEwIZDKhaU-3_JYzdtsaT9IKV_B6JKXfP__7gp_8H_hTclskIk8OcvUROVyvNuEZakxreJ5Z5BenyQ6z priority: 102 providerName: Springer Nature |
Title | First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody |
URI | https://link.springer.com/article/10.1038/s41467-022-28727-5 https://www.proquest.com/docview/2637648717 https://www.proquest.com/docview/2638022039 https://pubmed.ncbi.nlm.nih.gov/PMC8907355 https://doaj.org/article/42a11e0860df4b12b471a443fa8f7ecb |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1di9QwMNwHgi_iJ1bPJYJvGt0maZI-iOwtu64LHsd5eyy-lKZN7ipLq71dcP31TtJ2pccp-NKGZEKbzEwyk5nMIPRKi1yrzGZEhpoRHouc6IgzIjImLOw51nhzwecTMVvw-TJa7qEu3VE7gde3qnYun9SiXr39-WP7ARj-fXNlXL275p7dnV86yP9UkmgfHXp7kXPla8V9vzKzGBQa3t6dub1rb3_yYfx7sudNz8kb5lO_K03vo3utOIlHDf4foD1TPkR3mgST20fo27QA6Y4UJfG5-HDhboNUp5NzKPn0RLiyePbpgoS488oqsXOFv8Qq_loTIBHYlnJ8cTYehljXVZqvtrg0G38-8svBAWYKXeXbx2gxnZyPZ6TNrkCyKGRrYhnwrwTxiwmuuYxVrKXm6dBCOePcgKJmWe6srIxqQ3PKIi1NrrWLJ2Myyp6gg7IqzVOEUy5oLoaZlCbmkWEqHWoltdBMWxpTFaCwm9Mka0OPuwwYq8SbwJlKGjwkgIfE4yGJAvR61-d7E3jjn9DHDlU7SBc021dU9WXS8mDCaRqGBnS4YW65DimMOkw5ZzZVVppMB-ioQ3TSEWJCBSzBoNWFMkAvd83Ag86wkpam2ngYf2OZxQGSPQLp_VC_pSyufDRvFcMqG8EI3nSk9Ofjfx_ws_8Df47uUkfkznkuPkIH63pjXoA0tdYDtC-XEp5q-nGADkej-Zc5vI8nJ6dnUDsW44E_pxh4VvoNv0YfEQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTgheEFcRGGAkeAJrie3EzsOE2GjVsq2apm6aePHi2B5FUzJ6ESo_jt_GsZt06iT2treocdQ45-5zzncQeq8zo2XpSiISzQjPM0N0yhnJSpY5sDnOhnTB4TDrn_BvZ-nZBvrb9sL4sspWJwZFberSn5Fv0wxEAbzrRHy--kX81CifXW1HaBTNaAWzEyDGmsaOfbv4DSHcdGfwFej9gdJed7TXJ82UAVKmCZsRBwE92E3qkdQ1F7nMtdC8iB1cl5xbCFgcMz7byKi21FCWamGN1h5XxZYe-ABMwCb3BygdtLnbHR4dr055PP665Lzp1omZ3J7yoJt8ET0EK1SQdM0ihsEBa97uzVrNGwnbYAd7j9DDxoHFX5Yc9xht2OoJurccabl4in72xuBPknFFwvQ_PPb9J_VRdwRXYSASrh3uD05Jgts6sAr74vsLLPPvEwJMCYbQ4NPjvTjBelIX5nKBKzsPJzJ__DrghbGuzeIZOrmTL_0cdaq6si8QLnhGTRaXQticp5bJItZS6Ewz7WhOZYSS9puqsgE79zM3LlVIujOplnRQQAcV6KDSCH1cPXO1hPq4dfWuJ9VqpYfpDj_UkwvVSL3itEgSC1FjbBzXCYVdJwXnzBXSCVvqCG21hFaN7piqa06P0LvVbZB6n8opKlvPw5rQI83yCIk1Bll7ofU71fhHwA-XOej1FHbwqWWl6z___4Zf3v6ub9H9_ujwQB0Mhvuv0APqGdyX6uVbqDObzO1r8N1m-k0jIBid37VM_gNhxlKV |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIhAXxFOEFjASnMDaxHZi54AQtF3tUqgq1FYrLiaO7ZKqSso-hJafxq9j7CRbbSV66y1KHCX2vD3j-RB6rTOjZelKIhLNCM8zQ3TKGclKljmwOc6GdMHXg2x0zD9P0skG-tufhfFllb1ODIraNKXfIx_QDEQBvOtEDFxXFnG4O_xw8Yt4BCmfae3hNFoW2bfL3xC-zd6Pd4HWbygd7h3tjEiHMEDKNGFz4iCYB5tJfRd1zUUucy00L2IH1yXnFoIVx4zPNDKqLTWUpVpYo7XvqWJL3_QA1P8twTj3sBFiIlb7O77zuuS8O6cTMzmY8aCVfPk8hClUkHTNFgbIgDU_92qV5pVUbbCAw_voXue64o8trz1AG7Z-iG63YJbLR-hsWIEnSaqaBNw_XPmTJ83h3hFcBSgk3Dg8Gp-QBPcVYDX2ZfenWObfpwTYEUygwSffduIE62lTmPMlru0i7MX88eOACyrdmOVjdHwj6_wEbdZNbZ8iXPCMmiwuhbA5Ty2TRayl0Jlm2tGcyggl_Zqqsmtz7tE2zlVItzOpWjoooIMKdFBphN6u3rlom3xcO_qTJ9VqpG_QHW4001PVybvitEgSC_FibBzXCYVZJwXnzBXSCVvqCG33hFad1pipSx6P0KvVY5B3n8QpatsswphwOprlERJrDLL2Q-tP6upn6Bwuc9DoKczgXc9Klx___4SfXf-vL9EdkET1ZXywv4XuUs_fvkYv30ab8-nCPgenba5fBOnA6MdNi-M_EQJQMQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=First-in-human+immunoPET+imaging+of+HIV-1+infection+using+89Zr-labeled+VRC01+broadly+neutralizing+antibody&rft.jtitle=Nature+communications&rft.au=Beckford-Vera%2C+Denis+R.&rft.au=Flavell%2C+Robert+R.&rft.au=Seo%2C+Youngho&rft.au=Martinez-Ortiz%2C+Enrique&rft.date=2022-03-09&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2041-1723&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-022-28727-5&rft.externalDocID=10_1038_s41467_022_28727_5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |